Please login to the form below
OxyContin
This page shows the latest OxyContin news and features for those working in and with pharma, biotech and healthcare.
US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan
In a recent statement, the Sacklers said: “While the families have acted lawfully in all respects, they sincerely regret that OxyContin, a prescription medicine that continues to help people suffering from ... In 2019, Purdue filed for bankruptcy
Latest news
-
Purdue to pay over $8bn to settle opioid-related criminal claims
Purdue manufactured the prescription opioid painkiller OxyContin, which has become a focal point of the ongoing health crisis in the US.
-
Mallinckrodt files for bankruptcy protection in the US
The company made vast profits from its prescription painkiller OxyContin, with Purdue facing allegations of dishonest marketing relating to the opioid product as well as violations of the US Food, Drug
-
US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
Company faces new accusations of dishonest marketing tactics. New filings made by a number of US states claim that Purdue Pharma, the now infamous maker of OxyContin, owes $2.2 trillion ... The company made vast profits from its prescription painkiller
-
Mallinckrodt reaches tentative $1.6bn opioid settlement
Privately-owned pharma company Purdue Pharma, which manufactured OxyContin – the drug shouldering much of the blame for the crisis – filed for bankruptcy in September.
-
FDA committee rejects Intellipharmaceutics’ opioid drug Aximris
Oxycodone is the active ingredient of recently bankrupted Purdue Pharma’s OxyContin, a drug which had taken much of the brunt of blame for the opioid addiction epidemic in the US. ... Given the clinical make-up of the drug, the FDA compared its
More from news
Approximately 5 fully matching, plus 21 partially matching documents found.
Latest Intelligence
-
The transatlantic opioid crisis
Back in 2004, Purdue, manufacturer of the now notorious OxyContin, settled a case alleging inappropriate marketing for $10m.
-
Drug launches to watch in 2019
11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
"Legal highs" ruling leaves illegal labs laughing
Our agency was responsible for the EU launch of OxyContin and the first sublingual formulation of fentanyl, a powerful opioid that is abused by many drug addicts. ... So we are acutely aware of the devastation caused by the opioid epidemic in the US, and
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- NHS App to revolutionise digital health and care with major digital updates by 2023
- A new era for UK-Japanese scientific research relations
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
PMHub
Create Health
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
